Financial Summary (All financials)
| In millions, except per share items | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| Revenues | 35.2 | 69.1 | 5.2 | 0.0 |
| Revenue growth | -49.1% | 1217.6% | | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 35.2 | 69.1 | 5.2 | 0.0 |
| Gross margin | 100.0% | 100.0% | 100.0% | |
| Research and development | 74.1 | 40.5 | 25.4 | 22.3 |
| General and administrative | 19.8 | 11.5 | 6.4 | 4.8 |
| EBIT | -58.8 | 17.1 | -26.6 | -27.1 |
| EBIT margin | -167.1% | 24.8% | -506.7% | |
| Pre-tax income | -53.8 | 18.2 | -28.7 | -30.6 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | 0.0% | | |
| Net income | -53.8 | 4.9 | -28.7 | -30.6 |
| Net margin | -153.0% | 7.1% | -546.9% | |
| |
| Diluted EPS | ($2.09) | $0.57 | ($50.37) | ($59.89) |
| Shares outstanding (diluted) | 25.8 | 8.6 | 0.6 | 0.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|